Gilead

Read More
Less

Gilead says additional data on remdesivir shows improved clinical recovery

Findings from the analysis of its late-stage study showed that 74.4% of remdesivir-treated patients recovered by Day 14 versus 59.0% of patients receiving standard of care, the company said.

By REUTERS
10/07/2020
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy